Galapagos Stock Quote GLPG - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

26.56

Bid

26.34

Ask

27.14

Volume

112,312

26.38 Day's Range 26.98

26.38 52 Week Range 41.92

Market Cap

1.75B

Previous Close

27.12

Open

26.90

Last Trade

26.56

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

83,128

Shares Outstanding

65,897,000

Dividend Yield

PE Ratio

8.27

Earnings Per Share (EPS)

3.21

Revenue

843.8M

Net Profit

211.7M

Sector

Coml Physical, Biologcl Resh

Industry

Coml Physical, Biologcl Resh

Website

www.glpg.com

Headquarters

Mechelen, Antwerp, Bel

Founded

1970

Galapagos is listed in the Coml Physical, Biologcl Resh sector of the Euronext with ticker GLPG. The last closing price for Galapagos was 27.12 €. Over the last year, Galapagos shares have traded in a share price range of 26.38 € to 41.92 €.

Galapagos currently has 65,897,000 shares outstanding. The market capitalization of Galapagos is 1.75 € billion. Galapagos has a price to earnings ratio (PE ratio) of 8.27.

Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024

Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024 Two oral presentations and one poster on encore...

Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings

Publication of annual report for financial year 2023Annual Shareholders’ Meeting resolutions include approval of revised Remuneration Policy and (re)appointment of Board membersExtraordinary...

Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board

Mechelen, Belgium; 26 March 2024, 21:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that during its meeting of 26 March 2024, the Board of Directors appointed Mr. Dickinson as...

Galapagos announces full year 2023 results and outlook for 2024

Galapagos announces full year 2023 results and outlook for 2024 Full year 2023 key financials: Group net revenues of €783.5 million, including Jyseleca® net sales of €112.3 million Cash and...

Galapagos presents at EBMT-EHA annual meeting 2024

Showcases meaningful advances in decentralized CAR T-cell manufacturing and presents translational and clinical data from ongoing Phase 1/2 CD19 CAR-T studies Mechelen, Belgium; 15 February 2024...

Galapagos completes transaction to transfer Jyseleca® business to Alfasigma

Galapagos completes transaction to transfer Jyseleca® business to Alfasigma Mechelen, Belgium; 31 January 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced the...

Galapagos, Thermo Fisher to Collaborate on Expanding Manufacturing of Cancer Drug

By Ben Glickman Galapagos said it had entered an agreement with Thermo Fisher Scientific to expand manufacturing of its immune-cell cancer treatment candidate. The company said that Thermo Fisher...

Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.

Thermo Fisher Scientific to provide CAR-T manufacturing and kitting services for Galapagos’ point-of-care CAR-T product candidate in the San Francisco areaAgreement follows previously announced...

Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncology

Strategic collaboration and licensing agreement further strengthens Galapagos’ growing early-stage pipeline in oncology precision medicineCollaboration leverages Galapagos’ expertise in small...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.7	-2.56786500367	27.26	27.76	26.38	80584	27.3099041	DE
4	-3.78	-12.4588002637	30.34	30.42	26.38	86734	28.474048	DE
12	-8.44	-24.1142857143	35	37.17	26.38	83128	31.5966214	DE
26	-5.44	-17	32	39	26.38	86741	33.53837722	DE
52	-8.1	-23.3698788229	34.66	41.92	26.38	97203	35.49548635	DE
156	-40.93	-60.6460216328	67.49	69.27	26.38	227082	48.26515287	DE
260	-74.64	-73.7549407115	101.2	252.9	26.38	332322	103.72387053	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SGBXSafe and Green Holdings Corporation	$ 0.2349 (63.01%)	111.63M
ACONAclarion Inc	$ 0.45 (56.25%)	94.94M
YYGHYY Group Holding Ltd	$ 3.4499 (52.65%)	16.26M
PCSAProcessa Pharmaceuticals Inc	$ 2.24 (38.27%)	61.92M
BRFHBarfresh Food Group Inc	$ 1.42 (37.86%)	38.77M
EJHE Home Household Service Holdings Ltd	$ 0.7534 (-74.11%)	10.02M
CSSEChicken Soup for the Soul Entertainment Inc	$ 0.275912 (-35.13%)	13.34M
CYCCCyclacel Pharmaceuticals Inc	$ 1.545 (-32.82%)	3.04M
ATNIATN International Inc	$ 19.2999 (-32.80%)	206.45k
BNAIBrand Engagement Network Inc	$ 2.59 (-30.56%)	171.61k
SGBXSafe and Green Holdings Corporation	$ 0.2349 (63.01%)	111.63M
SQQQProShares UltraPro Short QQQ	$ 12.2027 (3.33%)	99.15M
ACONAclarion Inc	$ 0.45 (56.25%)	94.94M
TSLATesla Inc	$ 162.841 (0.44%)	69.69M
PCSAProcessa Pharmaceuticals Inc	$ 2.24 (38.27%)	61.92M